GR3032688T3 - 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them - Google Patents

17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number: GR3032688T3
Authority: GR; Greece
Prior art keywords: opt; desoxy; corticosteroid; esters; preparation
Prior art date: 1994-09-20

Application number

GR20000400386T

Other languages

English (en)

Inventor

Ulrich Dr Stache

Hans-Georg Dr Alpermann

Manfred Dr Bohn

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-20

Filing date

2000-02-18

Publication date

2000-06-30

2000-02-18 Application filed by Hoechst Ag filed Critical Hoechst Ag

2000-06-30 Publication of GR3032688T3 publication Critical patent/GR3032688T3/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)

GR20000400386T 1994-09-20 2000-02-18 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them GR3032688T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4433374A DE4433374A1 (de)	1994-09-20	1994-09-20	17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number	Publication Date
GR3032688T3 true GR3032688T3 (en)	2000-06-30

Family

ID=6528610

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR20000400386T GR3032688T3 (en)	1994-09-20	2000-02-18	17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them

Country Status (24)

Country	Link
US (1)	US5824670A (el)
EP (1)	EP0708111B1 (el)
JP (1)	JP3902255B2 (el)
KR (1)	KR100406627B1 (el)
CN (1)	CN1056151C (el)
AT (1)	ATE188480T1 (el)
AU (1)	AU695710B2 (el)
CA (1)	CA2158610C (el)
CZ (1)	CZ288297B6 (el)
DE (2)	DE4433374A1 (el)
DK (1)	DK0708111T3 (el)
ES (1)	ES2140596T3 (el)
FI (1)	FI114708B (el)
GR (1)	GR3032688T3 (el)
HU (1)	HU217438B (el)
IL (1)	IL115331A (el)
NO (1)	NO305210B1 (el)
NZ (1)	NZ280038A (el)
PL (1)	PL186071B1 (el)
PT (1)	PT708111E (el)
RU (1)	RU2161624C2 (el)
SI (1)	SI9500295B (el)
TW (1)	TW424094B (el)
ZA (1)	ZA957877B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2180216C2 (ru) *	2000-03-13	2002-03-10	Открытое акционерное общество "Биосинтез"	Препарат, обладающий антимикробным и регенерирующим действием
ES2565194T3 (es) *	2010-07-20	2016-04-01	Taro Pharmaceutical Industries Ltd	Procedimiento para la preparación de 17-desoxi-corticosteroides
US12209988B2 (en)	2019-05-24	2025-01-28	Electronics And Telecommunications Research Institute	Sensor and method of manufacturing the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2755292A (en) *	1952-01-21	1956-07-17	Organon Labor Ltd	Phenyl propionate of testosterone
US2783226A (en) *	1955-02-03	1957-02-26	Schering Corp	Esters of cortical hormones
ES229413A1 (es) *	1956-06-22	1956-11-01	Francisco Vismara S P A	UN PROCEDIMIENTO PARA LA PREPARACIoN DE COMPUESTOS ESTEROIDALES QUE CONTENGAN UN GRUPO CEToLICO EN LA CADENA LATERAL
DE1131668B (de) *	1959-07-16	1962-06-20	Leo Ab	Verfahren zur Herstellung von Estern von Corticosteroid-Hormonen
CH495969A (de) *	1965-11-09	1970-09-15	Schering Ag	Verfahren zur Herstellung neuer 21-Ester von 16a-Methyl-21-hydroxy- 1,4-steroiden
DE2047105C3 (de) *	1970-09-18	1979-02-15	Schering Ag, 1000 Berlin Und 4619 Bergkamen	17-Chlorsteroide und Verfahren zu ihrer Herstellung
US3956349A (en) *	1975-02-18	1976-05-11	Syntex (U.S.A.) Inc.	Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof
FR2342738A1 (fr) *	1976-03-02	1977-09-30	Roussel Uclaf	Nouveaux derives halogenes de la serie du 16a-methyl pregnane
DE2617655C2 (de) *	1976-04-21	1984-11-08	F. Hoffmann-La Roche & Co Ag, Basel	Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2645104C2 (de) *	1976-10-04	1986-04-24	Schering AG, 1000 Berlin und 4709 Bergkamen	11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
FR2381065A2 (fr) *	1977-02-22	1978-09-15	Roussel Uclaf	Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
US4086254A (en) *	1977-04-13	1978-04-25	The Upjohn Company	Photocleavable steroids
LU77457A1 (el) *	1977-05-31	1979-01-19
US4377573A (en) *	1978-01-06	1983-03-22	Leveen Harry H	Method of control of gastrointestinal bleeding
DE2817988A1 (de) *	1978-04-25	1979-11-08	Hoechst Ag	Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2920726A1 (de) *	1979-05-18	1980-11-27	Schering Ag	Neue kortikoide, ihre herstellung und verwendung
ATE3774T1 (de) *	1980-05-02	1983-06-15	Schering Corporation	Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
DE3260474D1 (en) *	1981-02-02	1984-09-06	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
SE8303031D0 (sv) *	1983-05-30	1983-05-30	Leo Ab	Improved steroid esters preparation
US4910191A (en) *	1988-06-28	1990-03-20	Merrell Dow Pharmaceuticals Inc.	19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US4920114A (en) *	1988-06-28	1990-04-24	Merrell Dow Pharmaceuticals Inc.	19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
NZ237559A (en) *	1990-04-02	1993-04-28	Merrell Dow Pharma	Halogenoethyl steroid derivatives and pharmaceutical compositions

1994
- 1994-09-20 DE DE4433374A patent/DE4433374A1/de not_active Withdrawn
1995
- 1995-09-08 TW TW084109384A patent/TW424094B/zh not_active IP Right Cessation
- 1995-09-15 DE DE59507565T patent/DE59507565D1/de not_active Expired - Lifetime
- 1995-09-15 PT PT95114511T patent/PT708111E/pt unknown
- 1995-09-15 EP EP95114511A patent/EP0708111B1/de not_active Expired - Lifetime
- 1995-09-15 AT AT95114511T patent/ATE188480T1/de active
- 1995-09-15 DK DK95114511T patent/DK0708111T3/da active
- 1995-09-15 ES ES95114511T patent/ES2140596T3/es not_active Expired - Lifetime
- 1995-09-18 CN CN95116294A patent/CN1056151C/zh not_active Expired - Fee Related
- 1995-09-18 CZ CZ19952425A patent/CZ288297B6/cs not_active IP Right Cessation
- 1995-09-18 NZ NZ280038A patent/NZ280038A/en not_active IP Right Cessation
- 1995-09-18 IL IL11533195A patent/IL115331A/en not_active IP Right Cessation
- 1995-09-18 US US08/529,668 patent/US5824670A/en not_active Expired - Lifetime
- 1995-09-18 AU AU31728/95A patent/AU695710B2/en not_active Ceased
- 1995-09-18 FI FI954394A patent/FI114708B/fi not_active IP Right Cessation
- 1995-09-19 PL PL95310544A patent/PL186071B1/pl not_active IP Right Cessation
- 1995-09-19 JP JP23939895A patent/JP3902255B2/ja not_active Expired - Fee Related
- 1995-09-19 CA CA002158610A patent/CA2158610C/en not_active Expired - Fee Related
- 1995-09-19 NO NO953695A patent/NO305210B1/no not_active IP Right Cessation
- 1995-09-19 RU RU95116371/04A patent/RU2161624C2/ru not_active IP Right Cessation
- 1995-09-19 ZA ZA957877A patent/ZA957877B/xx unknown
- 1995-09-19 HU HU9502735A patent/HU217438B/hu not_active IP Right Cessation
- 1995-09-20 SI SI9500295A patent/SI9500295B/sl unknown
- 1995-09-20 KR KR1019950030850A patent/KR100406627B1/ko not_active Expired - Fee Related
2000
- 2000-02-18 GR GR20000400386T patent/GR3032688T3/el unknown

Also Published As

Publication number	Publication date
CZ242595A3 (en)	1996-04-17
NO953695D0 (no)	1995-09-19
NO953695L (no)	1996-03-21
PL310544A1 (en)	1996-04-01
CN1124250A (zh)	1996-06-12
NZ280038A (en)	1997-03-24
DK0708111T3 (da)	2000-06-13
KR960010681A (ko)	1996-04-20
EP0708111A1 (de)	1996-04-24
FI954394L (fi)	1996-03-21
TW424094B (en)	2001-03-01
AU695710B2 (en)	1998-08-20
IL115331A0 (en)	1995-12-31
EP0708111B1 (de)	2000-01-05
FI114708B (fi)	2004-12-15
JP3902255B2 (ja)	2007-04-04
JPH0899992A (ja)	1996-04-16
US5824670A (en)	1998-10-20
ATE188480T1 (de)	2000-01-15
ZA957877B (en)	1996-04-03
AU3172895A (en)	1996-04-04
DE4433374A1 (de)	1996-03-21
DE59507565D1 (de)	2000-02-10
FI954394A0 (fi)	1995-09-18
IL115331A (en)	2002-07-25
CA2158610A1 (en)	1996-03-21
RU2161624C2 (ru)	2001-01-10
SI9500295A (en)	1996-04-30
CN1056151C (zh)	2000-09-06
CA2158610C (en)	2007-07-17
PL186071B1 (pl)	2003-10-31
HU217438B (hu)	2000-01-28
SI9500295B (en)	2001-12-31
PT708111E (pt)	2000-04-28
NO305210B1 (no)	1999-04-19
KR100406627B1 (ko)	2004-02-19
CZ288297B6 (en)	2001-05-16
HUT72969A (en)	1996-06-28
ES2140596T3 (es)	2000-03-01
HU9502735D0 (en)	1995-11-28

Publication	Publication Date	Title
IL90062A0 (en)	1989-12-15	Pyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
GR3018206T3 (en)	1996-02-29	Use of macrocyclic nitrogen containing compounds for the treatment of retroviral infections.
ATE121739T1 (de)	1995-05-15	Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.
DE3576690D1 (de)	1990-04-26	Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als anti-allergische mittel.
EP0292840A3 (en)	1990-04-11	Cyclic amine derivatives, medicaments containing these compounds and procedure for their preparation
WO2002059102A3 (fr)	2003-01-09	Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation
IE821768L (en)	1983-01-24	Pyrrolidine derivatives
ATE102210T1 (de)	1994-03-15	1h,3h,7-pyrrolo (1,2-c>thiazolcarbonsaeureamidderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
GR3032688T3 (en)	2000-06-30	17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them
ATE55250T1 (de)	1990-08-15	Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
ATE53209T1 (de)	1990-06-15	Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
ZA925782B (en)	1993-03-02	N-(isoquinolin-5-ylsulphonyl) azacycloalkanes, process for the preparation thereof and pharmaceutical compositions containing them.
HUT58097A (en)	1992-01-28	Process for producing 3,7-diazobicyclo(3,3.1)nonane compounds and pharmaceutical compositions comprising same
HUT57227A (en)	1991-11-28	2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance
GB8728314D0 (en)	1988-01-06	New compositions of matter
ATE101119T1 (de)	1994-02-15	Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
DE59105961D1 (de)	1995-08-17	2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.